CrestPoint Capital Management LLC held its position in Allstate Corp (NYSE:ALL) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,000 shares of the insurance provider’s stock at the end of the second quarter. CrestPoint Capital Management LLC’s holdings in Allstate Corp were worth $531,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. FNY Partners Fund LP bought a new position in Allstate Corp during the first quarter valued at $122,000. Bronfman E.L. Rothschild L.P. boosted its position in Allstate Corp by 8.5% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 1,550 shares of the insurance provider’s stock valued at $126,000 after buying an additional 122 shares during the last quarter. Oakworth Capital Inc. boosted its position in Allstate Corp by 505.8% in the first quarter. Oakworth Capital Inc. now owns 1,775 shares of the insurance provider’s stock valued at $145,000 after buying an additional 1,482 shares during the last quarter. Howard Hughes Medical Institute bought a new position in Allstate Corp during the first quarter valued at $160,000. Finally, Watermark Asset Management Inc. bought a new position in Allstate Corp during the first quarter valued at $170,000. 76.24% of the stock is owned by institutional investors.
Shares of Allstate Corp (NYSE ALL) opened at 89.25 on Thursday. The company has a market cap of $32.53 billion, a price-to-earnings ratio of 15.13 and a beta of 1.10. The stock has a 50 day moving average of $88.20 and a 200 day moving average of $82.36. Allstate Corp has a 12-month low of $66.55 and a 12-month high of $90.74.
Allstate Corp (NYSE:ALL) last announced its earnings results on Wednesday, May 3rd. The insurance provider reported $1.64 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.04 by $0.60. The company had revenue of $9.30 billion during the quarter, compared to analyst estimates of $8.36 billion. Allstate Corp had a net margin of 7.32% and a return on equity of 13.97%. Equities research analysts predict that Allstate Corp will post $6.06 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Thursday, August 31st will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 1.66%. The ex-dividend date of this dividend is Tuesday, August 29th. Allstate Corp’s dividend payout ratio (DPR) is presently 25.00%.
Several research firms recently weighed in on ALL. Wells Fargo & Company reaffirmed a “buy” rating on shares of Allstate Corp in a research note on Thursday. BidaskClub cut shares of Allstate Corp from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Citigroup Inc. lifted their price objective on shares of Allstate Corp from $97.00 to $102.00 and gave the stock a “buy” rating in a research note on Thursday, July 13th. FBR & Co lifted their price objective on shares of Allstate Corp from $70.00 to $82.00 and gave the stock a “mkt perform” rating in a research note on Monday, April 3rd. Finally, Credit Suisse Group set a $86.00 price objective on shares of Allstate Corp and gave the stock a “hold” rating in a research note on Saturday, March 25th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company’s stock. Allstate Corp has an average rating of “Buy” and a consensus target price of $87.67.
In other Allstate Corp news, insider Sanjay Gupta sold 16,798 shares of the stock in a transaction dated Thursday, May 25th. The shares were sold at an average price of $86.00, for a total transaction of $1,444,628.00. Following the completion of the transaction, the insider now owns 65,798 shares of the company’s stock, valued at $5,658,628. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Samuel H. Pilch sold 8,582 shares of the stock in a transaction dated Wednesday, May 3rd. The stock was sold at an average price of $83.88, for a total transaction of $719,858.16. Following the transaction, the vice president now directly owns 35,875 shares of the company’s stock, valued at approximately $3,009,195. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 179,259 shares of company stock valued at $15,695,746. 1.58% of the stock is currently owned by insiders.
Allstate Corp Company Profile
The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allstate Corp (NYSE:ALL).